The stock of Vigil Neuroscience Inc (NASDAQ: VIGL) has increased by 11.87 when compared to last closing price of 2.03.Despite this, the company has seen a gain of 18.28% in its stock price over the last five trading days. globenewswire.com reported 2025-01-23 that – Safety, tolerability, pharmacokinetic, and pharmacodynamic profile supports continued development of VG-3927 as potential once-daily oral therapy for Alzheimer’s disease (AD) –
Is It Worth Investing in Vigil Neuroscience Inc (NASDAQ: VIGL) Right Now?
The 36-month beta value for VIGL is at 1.82. Analysts have varying views on the stock, with 6 analysts rating it as a “buy,” 2 rating it as “overweight,” 0 as “hold,” and 1 as “sell.”
The public float for VIGL is 19.36M, and currently, shorts hold a 3.60% of that float. The average trading volume for VIGL on January 23, 2025 was 230.18K shares.
VIGL’s Market Performance
VIGL’s stock has seen a 18.28% increase for the week, with a 36.81% rise in the past month and a -40.86% fall in the past quarter. The volatility ratio for the week is 8.41%, and the volatility levels for the past 30 days are at 9.80% for Vigil Neuroscience Inc The simple moving average for the past 20 days is 24.95% for VIGL’s stock, with a -30.31% simple moving average for the past 200 days.
Analysts’ Opinion of VIGL
Morgan Stanley, on the other hand, stated in their research note that they expect to see VIGL reach a price target of $4, previously predicting the price at $13. The rating they have provided for VIGL stocks is “Underweight” according to the report published on December 19th, 2023.
JMP Securities gave a rating of “Mkt Outperform” to VIGL, setting the target price at $23 in the report published on October 18th of the previous year.
VIGL Trading at 0.42% from the 50-Day Moving Average
After a stumble in the market that brought VIGL to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -62.52% of loss for the given period.
Volatility was left at 9.80%, however, over the last 30 days, the volatility rate increased by 8.41%, as shares surge +32.94% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -36.69% lower at present.
During the last 5 trading sessions, VIGL rose by +17.71%, which changed the moving average for the period of 200-days by -32.13% in comparison to the 20-day moving average, which settled at $1.82. In addition, Vigil Neuroscience Inc saw 33.59% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at VIGL starting from Budd Haeberlein Samantha L., who purchase 12,000 shares at the price of $1.71 back on Dec 19 ’24. After this action, Budd Haeberlein Samantha L. now owns 12,000 shares of Vigil Neuroscience Inc, valued at $20,520 using the latest closing price.
Magovcevic-Liebisch Ivana, the President and CEO of Vigil Neuroscience Inc, purchase 5,000 shares at $1.68 during a trade that took place back on Dec 19 ’24, which means that Magovcevic-Liebisch Ivana is holding 222,687 shares at $8,400 based on the most recent closing price.
Stock Fundamentals for VIGL
Current profitability levels for the company are sitting at:
- -45.72 for the present operating margin
- 0.82 for the gross margin
The net margin for Vigil Neuroscience Inc stands at -42.71. The total capital return value is set at -0.88. Equity return is now at value -73.62, with -56.88 for asset returns.
Based on Vigil Neuroscience Inc (VIGL), the company’s capital structure generated 0.13 points at debt to capital in total, while cash flow to debt ratio is standing at -3.69. The debt to equity ratio resting at 0.15. The interest coverage ratio of the stock is -84.62.
Currently, EBITDA for the company is -88.47 million with net debt to EBITDA at 0.36. When we switch over and look at the enterprise to sales, we see a ratio of 35.7. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.72.
Conclusion
In conclusion, Vigil Neuroscience Inc (VIGL) has had a mixed performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
